CClinicalTrials.gg
CompletedNCT03871686Updated Feb 5, 2020

Promotion of Well-being of Young Adult Brain Cancer Survivors

An interventional study of Brief Internet-based Behavioral Activation Intervention in Brain Tumor, Pediatric, sponsored by University of Wisconsin, Madison. Completed at 1 site in United States. Open to participants aged 18 Years to 30 Years. Per ClinicalTrials.gov, last updated 2020-02-05.

Sponsored by University of Wisconsin, Madison · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
139
Allocation
Randomized
Ages
18 Years to 30 Years
Sex
All
01

Study summary

The purpose of this study is to evaluate the effectiveness of an Internet-based, behavioral activation intervention to promote well-being in a young adult survivors of childhood brain tumor.

Read the detailed description

Participants will be recruited through the Children's Brain Tumor Foundation who will share the study announcement with their young adult members and social media. Eligible participants will complete a baseline battery survey via Qualtrics. The investigators will recruit 120 participants. The survey will take approximately 30 minutes to complete. Participants will be randomly assigned to an experimental group or control group. The experimental group will take an Internet-based behavioral activation intervention. The intervention has four modules and will be administered via Qualtrics. A link to each module will be sent to the participants via e-mail. Participants will have one week to complete each module. Once a participant completes a module, the next module link will be sent after 3 days. A reminder will be sent at 7 days and 10 days until the module is complete. Each module will take approximately 30 minutes to complete. The experimental group may continue to receive services as usual from the Children's Brain Tumor Foundation. The control group will continue to receive services as usual from the Children's Brain Tumor Foundation. The control group will have an opportunity to take the intervention once data collection is complete. Both groups will be asked to complete a battery of surveys at the end of the intervention and intermittently over a 3-month period.

02

Conditions studied

  • Brain Tumor, Pediatric

Browse trials for

03

In context

Brain Neoplasms

1,960 studies on the registry are indexed under Brain Neoplasms; 516 are open to participants now.

This study's enrollment of 139 is above the median of 40 across 1,458 interventional studies indexed under Brain Neoplasms.

Browse Brain Neoplasms studies →

Lead sponsor

University of Wisconsin, Madison is the lead sponsor of 1,161 studies on the registry; 182 are open to participants now.

Of its 151 completed or terminated interventional studies of FDA-regulated products, 114 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • History of childhood brain tumor
  • Ages of 18 and 30 years.
  • Have regular access to the Internet
  • Provide an e-mail address

Exclusion criteria

Exclusion Criteria:

  • Those that do not meet the inclusion criteria.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
139 participants (actual)

Study arms

  • Experimental
    Experimental Group

    Participants will be asked to complete a brief online program over a 4 to 8-week period. Each week participants will be asked to complete one session of the program online. There are four sessions.

    Behavioral: Brief Internet-based Behavioral Activation Intervention

  • No intervention
    Control Group

    Participants will receive no intervention from the investigators. Participants may continue services as usual as provided by Children's Brain Tumor Foundation.

Interventions

  • BehavioralBrief Internet-based Behavioral Activation Intervention

    A brief Internet-based behavioral activation intervention consisting of 4 sessions.

    Also known as: Taking Action and Making Commitment: A Well-being Prorgram

06

What researchers measure

Primary outcomes

  1. Change from baseline PERMA-Profiler score at 2 weeks and 3 months

    The PERMA-Profiler is a general measure of well-being (Butler \& Kern, 2016). The PERMA-Profiler measures Seligman's (2011) five pillars of well-being: positive emotion, engagement, relationships, meaning, and accomplishment. The measure consists of 23 items, including three items for each domain. The health, negative emotion, loneliness, and overall happiness items act as filler questions and provide more information. Items are rated on an 11-point Likert scale ranging from 0 (never) to 10 (always), or 0 (not at all) to 10 (completely). Scores are calculated as the average of the items comprising each factor. Butler and Kern (2016) suggested that the multidimensional structure be retained, rather than condensing responses; however, a single well-being score may provide a global indication of well-being. Therefore, for the current study, total scores for each subscale will be calculated as well as the total scores. Change from baseline total score will be assessed.

    Time frame: At baseline; 2 weeks and 3 months after completing the intervention.

Secondary outcomes

  1. Change from baseline World Health Organization-Disability Assessment Schedule 2.0 score at 2 weeks and 3 months

    Measures overall health, functioning, and disability. Total scores range from 0 to 24. Scores are summed with higher scores indicating greater functional disability severity.

    Time frame: At baseline; 2 weeks and 3 months after completing the intervention.

  2. Change from baseline Life Satisfaction Scale (LiSat-9) score at 2 weeks and 3 months

    To measure satisfaction with life, the Life Satisfaction Questionnaire (LiSat-9; Fugl-Meyer et al., 1991) will be included. The LiSat-9 has 9 items; including one general life satisfaction item. There 8 are domain-specific items for vocational situation, financial situation, leisure, contact friends, sexual life, activities of daily living, family life, and partnership relationship. Items are rated on an Likert scale ranging from 1 (very dissatisfying) to 6 (very satisfying). Scoring consists of calculating the mean score. Higher scores indicate greater satisfaction with life.

    Time frame: At baseline; 2 weeks and 3 months after completing the intervention.

  3. Change in baseline Perceived Stress Scale score at 2 weeks and 3 months

    To measure perceived stress, the Perceived Stress Scale (PSS; Cohen \& Williamson, 1988) will be used. The PSS is a widely used 10-item scale in which respondents rate how stressful (unpredictable, uncontrollable, and overloaded) they perceive their lives to have been within the past month. Items are rated on a 5-point Likert scale ranging from 0 (never) to 4 (very often). Scoring consists of calculating the mean score. Higher scores indicate greater perceived stress.

    Time frame: At baseline; 2 weeks and 3 months after completing the intervention.

  4. Change in baseline Acceptance and Action Questionnaire (AAQ-II) score at 2 weeks and 3 months

    The Acceptance and Action Questionnaire (AAQ-II) (Bond et al., 2011) consists of seven items to be answered on a scale of 1 (never true) to 7 (always true). The AAQ-II measures participants' willingness to live in accordance with their values, in contact with negative private events, and acceptance of these events. A higher total score indicates a higher level of psychological flexibility, that is higher acceptance and less experiential avoidance. Total mean score will be calculated.

    Time frame: At baseline; 2 weeks and 3 months after completing the intervention.

  5. Change in baseline Behavioral Activation for Depression Scale (BADS-9) score at 2 weeks and 3 months

    The Behavioral Activation for Depression Scale- Short Form (BADS-9) is a 9-item scale with scores ranging from 0 to 54, with high scores representing higher activation. Total mean scores will be calculated.

    Time frame: At baseline; 2 weeks and 3 months after completing the intervention.

  6. Change in baseline Cognitive-Behavioral Social Self-Efficacy Scale score at 2 weeks and 3 months

    The Cognitive-Behavioral Social Self-Efficacy Scale is an 18-item measure of perceived social self-efficacy. Item scores range from 1 (not confident at all) to 5 (very confident. Total scores range from 18 to 90, with higher scores representing greater perceived social self-efficacy. Total mean scores will be calculated.

    Time frame: At baseline; 2 weeks and 3 months after completing the intervention.

  7. Change in baseline Vocational Outcomes Expectancy Scale score at 2 weeks and 3 months

    The Vocational Outcome Expectancy Scale (VOES) measures outcome expectancy related to employment. It is an 11-item scale with item scores ranging from 1 (strongly disagree) to 5 (strongly agree). Total scores range from 11 to 55, with higher scores representing a greater expectation of attaining positive employment outcomes (i.e., obtaining or retaining employment). Total mean scores will be calculated.

    Time frame: At baseline; 2 weeks and 3 months after completing the intervention.

  8. Change in baseline Perceived Barrier Scale score at 2 weeks and 3 months

    The Perceived Career Barriers measure was developed to identify barriers to career development and employment of young adult survivors of pediatric brain tumors (Strauser et al., 2018). The 12-item measure uses an 11-point Likert Scale (0-10) with 0 being (not a barrier) and 10 being a (major barrier). A midpoint label of (somewhat of a barrier) is utilized. Total scores range from 0 to 110, with higher scores indicating greater perceived career barriers.

    Time frame: At baseline; 2 weeks and 3 months after completing the intervention.

  9. Change in baseline General Self-Efficacy Scale score at 2 weeks and 3 months

    The General Self-Efficacy Scale (GSES) is a measure of general self-efficacy. It is a 10-item measure with item scores ranging from 1 (not true at all) to 4 (exactly true). Total scores range between 10 and 40, with a higher score indicating more self-efficacy.

    Time frame: At baseline; 2 weeks and 3 months after completing the intervention.

07

Study locations

1 site
  • Children's Brain Tumor Foundation
    New York, New York 10036, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 5, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03871686
Lead sponsor
University of Wisconsin, Madison
Responsible party
Sponsor
First posted
Mar 12, 2019
Start date
Feb 13, 2019
Primary completion
May 19, 2019
Completion
May 19, 2019
Last update
Feb 5, 2020

Study contacts

Timothy Tansey, PhD
principal investigator · University of Wisconsin, Madison

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion